Don't Buy Hims & Hers Stock If You Want Better Than Mediocre Returns
What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...
Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...
What's Going On With Hims & Hers Health Stock?
Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst expectations.
Hims and Hers Health put volume heavy and directionally bearish
Bearish flow noted in Hims and Hers Health with 25,948 puts trading, or 1.4x expected. Most active are Mar-25 27 puts and Jan-25 26 puts, with ...
Hims & Hers: Ready For Liftoff In 2025
Hims & Hers' robust Q3 2024 performance, driven by a 44% increase in subscribers and 77% y/y revenue growth, underscores its ...
What 12 Analyst Ratings Have To Say About Hims & Hers Health
Ratings for Hims & Hers Health HIMS were provided by 12 analysts in the past three months, showcasing a mix of bullish and ...
Is Hims & Hers Health a Millionaire Maker?
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.
6 Best Weight Loss Treatments: Ranking Top Weight Loss Solutions of 2025
Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...
Hims & Hers Health: Undervalued Growth Potential Amidst Digital Health Expansion
Analyst Ryan MacDonald of Needham maintained a Buy rating on Hims & Hers Health (HIMS – Research Report), boosting the price target to ...
DMR News (English) on MSN16h
Hims & Hers Makes Waves: $1 Million Donation Tied to GLP-1 Support
In a notable move, Hims & Hers Health donated $1 million to President-elect Donald Trump’s inauguration fund, signaling its ...